Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Kanoria Chemicals & Industries share price today

KANORICHEMChemicals - organic - alcohol basedConsolidatedPrices to 18 Nov 2026Results to Sep 2026

Price, 200-day average and NIFTY 500

The price is 25.8% above its 200-day average and 53 points behind the NIFTY 500 over 5 years

18 Nov 2026₹170.01Over 5 years: Kanoria Chemicals & Industries +2.2%, NIFTY 500 +55.7%
₹100₹200Nov 22Nov 24Nov 26

Price growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y+123.8%3Y+10.0%/yr5Y+0.4%/yr10Y+9.6%/yr

EPS and P/E

EPS ₹19.28, up 159% in a year; P/E 8.8

18 Nov 2026₹19.28 EPS
Dec 21
Mar 22
Jun 22
Sep 22
Dec 22
Mar 23
Jun 23
Sep 23
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
Nov 26
₹40−₹20

EPS growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y+158.8%3YNot meaningful5Y+13.2%/yr10YToo short

Revenue and margins

Revenue up on a year for 2 quarters in a row; operating margin 12.0%, the highest on this chart

Sep 2026 quarter₹358 crore+70.5% on ₹210 crore a year earlier · NPM 6.4%
Mar 23
Jun 23
Sep 23
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
0₹600

Revenue: 1Y change, then growth a year; margins are averages

Revenue growth1Y+35.8%3Y−14.7%/yr to Mar5Y−2.2%/yr to Mar10Y+5.7%/yr to Mar
OPM average3Y6.1%5Y4.8% to Mar
NPM average3Y0.7%5Y-1.0% to Mar

Return on capital

ROCE was 6.0% for the year to Mar 2026, up from 3.9% in the year to Mar 2021

Year to Mar 20266.0% ROCE
5%10%Mar 22Mar 24Mar 26

ROCE average

1Y3Y5Y10Y1Y6.0% to Mar3Y2.6% to Mar5Y2.5% to Mar10Y2.2% to Mar

Profit and cash

Cash from operations was ₹66 crore in the year to Mar 2026, against profit of ₹113 crore; profit over five years is a loss (−₹61 crore), so cash as a share of profit has no meaning

Yearly profit, cash from operations and free cash flow, ₹ crore

FY26₹66 crore operating cashFree cash ₹13 crore
FY22
FY23
FY24
FY25
FY26
₹200−₹100

Profit growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y+844.4%3YNot meaningful5Y+47.8%/yr to Mar10YNot meaningful

Reinvestment

Capex was ₹59 crore in the year to Mar 2026, 1.7 times depreciation

FY26₹59 crore capexWork in progress ₹32 crore
FY22
FY23
FY24
FY25
FY26
0₹100

Capex growth: 1Y change, then growth a year

1Y3Y5Y10Y1Y+10.0% to Mar3Y+0.8%/yr to Mar5YToo short10YToo short

BorrowingsInsufficient history, from Mar 2023Insufficient history, from Mar 2023

Debt ÷ equity 0.35 at 30 Sep 2026; profit covered interest 4.1x over the last four quarters

Sep 2026 balance sheet0.35 debt ÷ equityNet debt ₹281 crore
Mar 23
Jun 23
Sep 23
Dec 23
Mar 24
Jun 24
Sep 24
Dec 24
Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
12.5x-2.5x

Safety

Now3Y ago
Debt ÷ equity0.353Y ago0.75
Int. cover4.1x3Y ago0.7x

Operating health

Working capital fell from 16 to -14 days in 5 years; below zero, customers' advance payments and other dues are larger than the money tied up in the business

Year to Mar 2026-14 days working capital
0150Mar 22Mar 24Mar 26
Working cap.-141Y−63Y−225Y−30
Debtor501Y−653Y+55Y−18
Inventory551Y−1133Y−365Y−29

OwnershipInsufficient history, from Jun 2023Insufficient history, from Jun 2023

FIIs own 0.07%, up 0.03 points in a year. Promoters hold 74.39%

Share of the company held, %, by quarter end

Sep 2026 quarter0.07% FIIs
0%60%Sep 23Sep 24Sep 25Sep 26

Change in holding, in points

FIIs1Y+0.033Y+0.03
Promoters1Y0.003Y0.00

Kanoria Chemicals & Industries Ltd · KANORICHEM · Chemicals - Organic - Alcohol Based · price as of the 18 November 2026 close, updated every trading day · results updated weekly · research updated 10 October 2026

Kanoria Chemicals & Industries share price today: ₹170.01 at the close on 18 November 2026. Kanoria Chemicals & Industries (KANORICHEM) is worth ₹743 crore and trades at a P/E of 8.8. Latest change: profit down, share price ahead of the market.

₹170.01Price
8.8×P/E lower than 99% of the last 10 years
₹358 CrRevenue (Sep 2026) +70.5% on a year ago
₹23.0 CrProfit (Sep 2026) −75.0% on a year ago
12.0%Operating margin +9.1 points on a year ago
6.0%ROCE year to Mar 2026

Kanoria Chemicals & Industries Ltd's multiple is near its low because earnings grew even faster than a big multi-year rise in the share price. The multiple is low because of growth, not neglect. Results are still improving, and its P/E is higher than only 1% of its own 10-year history.

Biggest thing to watch: the price has already been rising for 25 weeks, so timing is the risk more than the business.

The price has been rising for 25 weeks, and the P/E is lower than 99% of its own last 10 years. Over the last four quarters, results have been improving, with profit −75.0% on a year earlier, and 176% of the last 3 years' profit came in as cash. What will decide it: the next one or two quarters of results.

Left out of this page: Its two data sources disagree by up to 181% on reported income across 13 comparable periods, so nothing from the second source is shown here. That is why the quarterly PEG curve, the yearly return-on-capital-used (ROIC) line, the total-debt and debt-to-equity series and the F-score and the return-on-capital-used (ROIC) reading are missing. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. The quarterly history also starts where the main source starts: 6 earlier quarters from the second source are not added in front of it. Adding to a profit history needs a source that has been checked.

What is the Kanoria Chemicals & Industries share price today?

Kanoria Chemicals & Industries Ltd's share price was ₹170.01 at the close on 18 November 2026. It has been rising for 25 weeks. That is 25.8% above its average price over the last 200 trading days. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 19 weeks in a row.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Kanoria Chemicals & Industries Ltd is in stage 2. The phase helps read everything below.

Since its first close in our records, on 8 May 2026, it has traded between ₹87 and ₹199, and at that close it sat 74% of the way up from that low.

Week by week since 2026: did it beat the NIFTY 500 over the past 13 weeks?

Ahead in 19 of 19 weeks

Week by week since 2026: did it beat the NIFTY 500 over the past 13 weeks?
Week13-week return vs NIFTY 500
8 May 2026no NIFTY 500 reading
15 May 2026no NIFTY 500 reading
22 May 2026no NIFTY 500 reading
29 May 2026no NIFTY 500 reading
5 Jun 2026no NIFTY 500 reading
12 Jun 2026no NIFTY 500 reading
19 Jun 2026no NIFTY 500 reading
25 Jun 2026no NIFTY 500 reading
1 Jul 2026no NIFTY 500 reading
3 Jul 2026no NIFTY 500 reading
10 Jul 2026no NIFTY 500 reading
17 Jul 2026no NIFTY 500 reading
24 Jul 2026no NIFTY 500 reading
31 Jul 2026+48.0%
7 Aug 2026+46.9%
14 Aug 2026+70.6%
21 Aug 2026+52.2%
28 Aug 2026+67.2%
4 Sep 2026+57.7%
11 Sep 2026+41.7%
18 Sep 2026+40.6%
25 Sep 2026+54.7%
28 Sep 2026+45.6%
1 Oct 2026+45.0%
9 Oct 2026+29.3%
16 Oct 2026+18.9%
23 Oct 2026+26.5%
30 Oct 2026+19.5%
6 Nov 2026+8.3%
8 Nov 2026+8.3%
13 Nov 2026+14.6%
18 Nov 2026+7.2%
Each bar is one week, from 2026 to now (19 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the NIFTY 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 6 months the share price moved +79% while the NIFTY 500 moved +3%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What changed at Kanoria Chemicals & Industries this quarter?

  1. Best operating margin in 15 quarters

    Operating margin was 12% in the September 2026 quarter, against 3% a year earlier.

What are Kanoria Chemicals & Industries' latest quarterly results?

For July to September 2026 (the quarter ended 30 September 2026), Kanoria Chemicals & Industries reported revenue of ₹358 crore, up 70.5% from ₹210 crore a year earlier, and a profit of ₹23.0 crore, down 75.0% from ₹92.0 crore.

Kanoria Chemicals & Industries results: July to September 2026 against a year earlier

Kanoria Chemicals & Industries results: July to September 2026 against a year earlier
MeasureJuly to September 2026July to September 2025Change
Revenue₹358 crore₹210 crore+70.5%
Profit₹23.0 crore₹92.0 crore−75.0%
Earnings per share₹5.20₹21.39−75.7%
Operating margin12.0%2.9%+9.1 points

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

What is the Kanoria Chemicals & Industries share price history?

Kanoria Chemicals & Industries closed at ₹170.01 on 18 November 2026. Its highest weekly close since May 2026 was ₹198.55 on 25 September 2026.

Kanoria Chemicals & Industries share price: then and now

Kanoria Chemicals & Industries share price: then and now
WhenCloseChange to 18 Nov 2026
1 week ago · 11 Nov 2026₹171.26−0.7%
1 month ago · 19 Oct 2026₹178.32−4.7%
6 months ago · 15 May 2026₹98.41+72.8%
Earliest weekly close in our records · 8 May 2026₹95.22+78.5%
Highest weekly close since May 2026 · 25 Sep 2026₹198.55−14.4%
Lowest weekly close since May 2026 · 22 May 2026₹87.13+95.1%

Weekly closing prices. Each change is the move from that price to the 18 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

32 weekly closes from 8 May 2026 to 18 November 2026.

What is the latest news on Kanoria Chemicals & Industries?

18 Nov 2026: Kanoria Chemicals & Industries closed at ₹170.01, down 0.7% on the week and down 4.7% on the month. Results for July to September 2026: Revenue up 70.5% and profit down 75.0% on a year earlier.

What dividend does Kanoria Chemicals & Industries pay?

Kanoria Chemicals & Industries paid no dividend in the 12 months to 18 November 2026. The last was a dividend of ₹1 a share, ex-date 24 August 2022.

Kanoria Chemicals & Industries dividends since 1 April 2021

Kanoria Chemicals & Industries dividends since 1 April 2021
Ex-dateDividend per shareType
24 Aug 2022Dividend₹1Dividend

Amounts as the company declared them on the exchange. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

1 of 5Of the last 5 financial years, years with an exchange dividend record

Not in its latest year. Kanoria Chemicals & Industries Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 3 of its last 12 reported years, so there is a history but no current dividend.

From the exchange corporate-actions record, read 18 November 2026.

What to watch in Kanoria Chemicals & Industries' next results?

When Kanoria Chemicals & Industries reports October to December 2026, these are the 3 checks that show whether the story is still on course. First: Revenue against the same quarter a year earlier.

  • Revenue against the same quarter a year earlier. In the Sep 2026 quarter, revenue was +70.5% on a year earlier, and the last four quarters averaged +54.4%.
  • Whether the operating margin stays near 12.0%. It is 9.1 percentage points higher than four quarters earlier.
  • Net profit against the same quarter a year earlier. In the Sep 2026 quarter, profit was −75.0% on a year earlier.

Which stock lists is Kanoria Chemicals & Industries on?

Kanoria Chemicals & Industries is on one of our India lists: Momentum stocks.

Is Kanoria Chemicals & Industries profitable?

Kanoria Chemicals & Industries Ltd earned ₹23.0 Cr of net profit in the Sep 2026 quarter, −75.0% on the same quarter a year earlier. Full-year FY26 profit was ₹113 Cr. The Sep 2026 quarter's profit is 6.4% of that quarter's revenue. The same quarter a year earlier earned ₹92.0 Cr. 7 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

How much revenue does Kanoria Chemicals & Industries make, and is it growing?

Kanoria Chemicals & Industries Ltd reported ₹358 Cr of revenue in the Sep 2026 quarter, +70.5% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 10 years it has grown 5.7% a year on average. The last full year, FY26, came in at ₹981 Cr.

Revenue is everything the company billed its customers in the period.

Why this happened. The latest operating-profit increase provides evidence of better trading performance. Management's efficiency commentary supports the direction, but the split between volume, mix, input costs and pricing remains undisclosed. Higher sales do not establish that all incremental revenue becomes recurring profit.

The last four reported quarters add to ₹1,388 Cr.

FY26 revenue was ₹981 Cr, +30.1% on the year before.

Recent pace: the last four quarters grew +54.4% on average, against 5.7% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +35.8%, against +4.8% a year over the last 8 quarters (accelerating).

Watch next

Metric
Operating recovery
Threshold
Operating profit falls as revenue grows, indicating that mix, pricing or input costs absorb the incremental volume.
Which result
the next result

How much of every ₹100 of sales does Kanoria Chemicals & Industries keep?

Kanoria Chemicals & Industries Ltd's operating margin was 12.0% in the Sep 2026 quarter, 9.1 percentage points higher than the same quarter a year ago. Across 12 years it has been between 2.8% and 8.6%. The latest quarter is above every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +9.1 percentage points on the year while gross margin changed −0.6 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

Is Kanoria Chemicals & Industries' profit turning into cash?

Over the last 3 years, 176% of Kanoria Chemicals & Industries Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹66.0 Cr of operating cash against ₹113 Cr of profit. After ₹59.0 Cr of spending on assets, ₹12.0 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 176% of profit came in as cash: the cash cycle got 41 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner.

What to look at next: the bigger use of cash is spending on new assets, at 1.5× depreciation over three years. The next section checks what that spending is building.

Where does Kanoria Chemicals & Industries' cash go?

Kanoria Chemicals & Industries Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 34 days in FY26, down from 75 days in FY21. It spent ₹194 Cr on assets over the last 3 years. Customers take 50 days to pay, and stock sits for 55 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Why this happened. The earlier Formaldehyde expansion has a disclosed completion outcome. Installed assets could support incremental volumes, but neither current spare capacity nor the contribution from this specific expansion is disclosed. Its benefit overlaps with operating recovery and is not counted as a separate proven profit stream. The website's 300 MTPD announcement and 345 MTPD commissioning disclosure describe different project stages; their engineering-capacity reconciliation remains undisclosed.

At FY26 sales of ₹981 Cr, each day of that cycle ties up about ₹2.7 Cr, so roughly ₹91.0 Cr is tied up in the business at any time.

FY26: customers took 50 days to pay and stock sat for 55 days, about 1.8 months of sales sitting as stock, for a full cycle of 34 days, shorter than FY21's 75.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 55 days. Customers pay about 50 days after that. Suppliers are paid at 70 days. Together that makes the 34-day cycle.

Spending on assets: ₹194 Cr over the last 3 years, against ₹126 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹32.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Watch next

Metric
Installed Formaldehyde capacity
Threshold
Additional production is absorbed only through lower realization or fails to earn its financing and operating costs.
Which result
the next result

What is Kanoria Chemicals & Industries' P/E ratio, and how does it compare with its own history?

Kanoria Chemicals & Industries Ltd's P/E is 8.8×, about the lowest it has ever been. Its usual P/E (the middle reading) is 25.0×, over 10 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

8.8×P/E · lower than 99% of its last 10 years

Where the price move came from: over 5 years the price moved +0.4% a year; about +13.2% a year came from earnings growth and about −12.8 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple.

A quarterly PEG curve, which only the second data source has, is not shown on this page: its two data sources disagree by up to 181% on reported income across 13 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.

What growth does the Kanoria Chemicals & Industries share price assume?

Worked out from its price on 11 October 2026, Kanoria Chemicals & Industries Ltd's share price assumed profit growth of about −4.5% a year. Today its P/E is 8.8×, lower than 99% of its own last 10 years.

This works the share price backwards. It asks one question: what yearly profit growth does the price already assume? The answer is the growth rate at which eleven years of profit (six years of growth, then five years of slowing) add up to that day's market value, after each year is discounted at 11%.

This is a one-day reading, taken on 11 October 2026. Every other number on this page, the multiple included, uses the latest price as of 18 November 2026. A higher price assumes more growth and a lower price less, so it changes whenever the price changes, and this page does not update it between measurements.

Is the Kanoria Chemicals & Industries business getting better or worse?

Kanoria Chemicals & Industries Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 8 quarters of 2 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

FlatRevenue growth · latest (Sep 2026) +35.8%, range −32.2% to +35.8%
RisingROCE · latest (year to Mar 2026) 6.0%, range 1.0% to 6.0%

Why it matters: with too little history, we say so rather than guess a direction.

The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone.

There are fewer than eight usable quarters, so this page does not guess a direction from so little history.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+30.1%−14.7%−2.2%+5.7%
Profit——+47.8%—
EPS——+52.8%—
Share price+123.8%+10.0%+0.4%+9.6%
+70.5%Revenue growth (Sep 2026) · latest quarter against a year ago
−75.0%Profit growth (Sep 2026) · latest quarter against a year ago
5.7%Revenue, 10 years · yearly growth over the long run

What is the Kanoria Chemicals & Industries story, and has it been checked?

Kanoria Chemicals & Industries Ltd's story is not scored yet against the checks our research set on 10 October 2026.

NOT YET CHECKED

From the numbers. The weekly snapshot separately labels the matrix RIDING WAVE, while…

From the price. Price stage 2, week 25, above its 200-day line, relative strength falling.

What the company does. Revenue and operating profit have improved, while the reported profit sequence mixes operating delivery with discontinued-business and tax effects. Triacetin provides a dated product addition, but commercial ramp, sustainable margins and cash retention remain unproven; Bronze evidence supports a cautious forecast.

The key numbers to watch, and the level that would change the picture

The key numbers to watch, and the level that would change the picture
MeasureWhy it mattersWhat to watch
Operating recoveryRevenue and operating profit improve independently of the exceptional profit spike.Operating profit falls as revenue grows, indicating that mix, pricing or input costs absorb the incremental volume.
Triacetin product additionA disclosed launch creates a commercial ramp to verify.The company reports commissioning without repeat commercial orders or positive product contribution.
Installed Formaldehyde capacityPreviously commissioned capacity offers a utilization lever.Additional production is absorbed only through lower realization or fails to earn its financing and operating costs.
Further diversification and process…Management identifies additional projects, with economics still to be disclosed.Project schedules slip or commissioning is followed by cash requirements without disclosed recurring returns.

Everything further down this page is evidence for or against these.

The numbersmargins at a record, multiple below its usual levelFY26-Q2 to FY27-Q1
The pricerising, above the 200-day averageFY26-Q2 to FY27-Q1
The whymargins at a record, multiple below its usual levelFY26-Q2 to FY27-Q1

FY26-Q2FY27-Q1

What the surface reading misses. The surface reading is: The latest operating and profit results suggest recovery. The research reads it further: Operating profit improves, but reported PAT also includes a financing-related other-income gain. Product-level volume, price and gross-margin contributions are not isolated.

What the surface reading misses. The surface reading is: Reported profit suggests a large improvement. The research reads it further: Operating profit improves despite lower revenue, but negative taxation lifts PAT beyond recurring pretax earnings.

  • 1 · Operating leveragequiet
  • 2 · Value-added mixquiet
  • 3 · Management changequiet
  • 4 · Paying down debtquiet
  • 5 · Regulatory approvalquiet
  • 6 · Order-book winsquiet
  • 7 · Consolidationquiet
  • 8 · Demerger or value unlockquiet
  • 9 · Buybackquiet
  • 10 · New geographiesquiet
  • 11 · More business from existing customersquiet
  • 12 · New product launchbuilding
  • 13 · Mandatory normsquiet
  • 14 · A bigger market to servequiet
  • 15 · Market-share gainsquiet
  • 16 · Asset qualityquiet

Lever 12 · New product launch: building. A disclosed launch creates a commercial ramp to verify. What proves it keeps working: Triacetin product addition. It stops working if The company reports commissioning without repeat commercial orders or positive product contribution.

Sources: our stock research file (10 October 2026) · quarterly results through Sep 2026. The story check is re-scored every results season; the record below never changes.

The whole page in one table. Each row links to its section.

The whole page in one table. Each row links to its section.
SectionWhere it is nowThe one thing to watch next
Revenue₹460 CrOperating recovery
Capexsee the sectionInstalled Formaldehyde capacity

How much does Kanoria Chemicals & Industries earn on its capital?

Kanoria Chemicals & Industries Ltd earned a ROCE of 6% in FY26. That is up from a low of −1% in FY20. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 11.5% net margin and 0.88× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 11.5% net margin × 0.88× asset turnover × 1.95× leverage (assets divided by equity) ≈ 19.7% on equity. The margin does its share; borrowing is a big part of it.

The quarterly return lines and the return-on-capital-used (ROIC) line, which only the second data source has, are not shown on this page: its two data sources disagree by up to 181% on reported income across 13 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.

Does Kanoria Chemicals & Industries have too much debt?

Kanoria Chemicals & Industries Ltd had ₹291 Cr of borrowings against ₹573 Cr of equity in FY26, so its debt is 0.51× its equity. Its operating profit is 2 times its interest bill. Over 5 years borrowings went from ₹493 Cr to ₹291 Cr. Over the last 3 of those years it spent ₹194 Cr on assets.

Debt-to-equity shows how much of the business is paid for with borrowed money. Interest cover shows how many times operating profit pays the interest bill. Low debt and high cover are the safe combination.

The spending on assets is being paid for from cash, not new debt.

The total-debt and debt-to-equity series, which only the second data source has, are not shown on this page: its two data sources disagree by up to 181% on reported income across 13 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.

What is the Kanoria Chemicals & Industries shareholding pattern?

No group of Kanoria Chemicals & Industries Ltd's owners changed its stake by a full percentage point over the last two years. Foreign institutions moved +0.0 points over the same period, to 0.1%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Promoters: +0.0 points over 8 quarters, to 74.4%; Foreign institutions: +0.0 points over 8 quarters, to 0.1%; Domestic institutions: +0.0 points over 8 quarters, to 0.1%.

How far is Kanoria Chemicals & Industries from balance-sheet trouble?

For Kanoria Chemicals & Industries Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

How does Kanoria Chemicals & Industries rank in its industry?

58.6 out of 100, rank 1 of 1 in Chemicals - Organic - Alcohol Based, with 57% of the evidence available.

Kanoria Chemicals & Industries Ltd scores 58.6 out of 100 against the 1 companies it is compared with in Chemicals - Organic - Alcohol Based, ranking 1. Some evidence is missing, so the score is pulled toward the middle on purpose.

The four parts add up to the total exactly: 31.3 + 4.8 + 10 + 12.5 = 58.6. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Kanoria Chemicals & Industries compared with?

Kanoria Chemicals & Industries ranks 1 of 1 Chemicals - Organic - Alcohol Based companies on the 4-Factor Sector Score, with 58.6 out of 100.

  1. 1Kanoria Chemicals & Industries Ltd this pageKANORICHEM · breaking out · Too little evidence to rank firmly · 57% evidence58.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 31.3/35 · Revenue 35.8% · Profit 100% · Operating margin change 9 points · 95% evidenceCapital efficiency 4.8/25 · ROCE 6% (year to Mar 2026) · Operating margin 12% · 76% evidenceValuation 10.0/20 · P/E 8.8× · PEG — · 0% evidenceRelative strength 12.5/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) 57.9% · 1 year — · 25% evidence · 12 of 12 weeks aheadExact sum: 31.3 + 4.8 + 10 + 12.5 = 58.6 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

In this ranking every company's P/E uses its own latest official close and its last four filed quarters, the same rule as the top of this page. ROCE here is each company's last full year, as labelled, so it can differ from the four-quarter ROCE above. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Chemicals - Organic - Alcohol Based, all 1 compared on one page.

Which companies are close to Kanoria Chemicals & Industries in size?

Kanoria Chemicals & Industries is the only Chemicals - Organic - Alcohol Based company on Sector Alpha, so the companies closest to it in market value across all industries are listed: Capital India Finance, Danlaw Technologies India, Indo SMC and Shree Rama Multi-Tech.

Companies close in size in other industries

  1. Capital India Finance Ltd ₹745 crore · Finance & Investments - Others
  2. Danlaw Technologies India Ltd ₹743 crore · IT - Software
  3. Kanoria Chemicals & Industries Ltd ₹743 crore
  4. Indo SMC Ltd ₹742 crore · Electric Equipment - General
  5. Shree Rama Multi-Tech Ltd ₹742 crore · Packaging - Laminates

What else do people ask about Kanoria Chemicals & Industries?

What were Kanoria Chemicals & Industries's latest quarterly results?

Kanoria Chemicals & Industries Ltd reported revenue of ₹358 Cr and net profit of ₹23.0 Cr for the Sep 2026 quarter. Revenue rose 70.5% and profit fell 75.0% compared with a year earlier. Earnings per share were ₹5.20 (as of 18 November 2026).

What is Kanoria Chemicals & Industries's market cap?

Kanoria Chemicals & Industries Ltd's market capitalisation is ₹743 Cr at a share price of ₹170.01. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 18 November 2026).

How is Kanoria Chemicals & Industries performing?

Kanoria Chemicals & Industries Ltd's share price has been rising for 25 weeks. In its latest quarter, revenue rose 70.5% and profit fell 75.0% compared with a year earlier.

Over the past 13 weeks it has done better than the NIFTY 500, for 19 weeks running (as of 18 November 2026).

Will Kanoria Chemicals & Industries's share price go up?

This page does not forecast Kanoria Chemicals & Industries Ltd's share price. What it shows instead: the share price is ₹170.01, and it has been rising for 25 weeks. Its P/E of 8.8× is higher than 1% of its own last 10 years (as of 18 November 2026).

Who owns Kanoria Chemicals & Industries?

Promoters own 74.4% of Kanoria Chemicals & Industries Ltd, foreign institutions 0.1%, domestic institutions 0.1% and the public 25.5% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 18 November 2026).

Does Kanoria Chemicals & Industries have too much debt?

Kanoria Chemicals & Industries Ltd has a moderate amount of debt: its debt is 0.35× its equity, and its operating profit is 4 times its interest bill. At Sep 2026 borrowings were ₹221 Cr against equity of ₹623 Cr.

Keep that borrowing in mind when reading the returns on this page (as of 18 November 2026).

Where is Kanoria Chemicals & Industries in its business cycle?

Kanoria Chemicals & Industries Ltd's FY26 operating margin was 7.2%, against a 12-year range of 2.8% to 8.6%. The latest quarter was 12.0%, above the top of its own yearly range in the latest quarter, so margins are at a high and the story depends on them staying there.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 18 November 2026).

What could break the Kanoria Chemicals & Industries story?

Biggest thing to watch: the price has already been rising for 25 weeks, so timing is the risk more than the business.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 18 November 2026).

Is Kanoria Chemicals & Industries a stock worth studying right now?

What the numbers show: Kanoria Chemicals & Industries Ltd's multiple is near its low because earnings grew even faster than a big multi-year rise in the share price. The multiple is low because of growth, not neglect.

Results are still improving, and its P/E is higher than only 1% of its own 10-year history. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 18 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 18 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.